Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504790
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2007-07-18
Brief Title:
Phase I Study to Assess the Safety Pharmacokinetics Pharmacodynamics of GSK923295 in Subjects w Refractory Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2012-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-18
First Submit QC Date:
July 18 2007
Study First Post Date:
2007-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-10
Last Update Post Date:
2018-07-12
Last Update Post Date Type:
ACTUAL